Cyrus Mozayeni is the founder of Vedere Bio. Vedere Bio has raised $77M in total funding. Latest round: Series A.
Cyrus Mozayeni is a biotech executive known for his involvement with Vedere Bio II, a company focused on developing gene therapy for vision loss. He was part of Vedere Bio II's leadership team and later became President & CEO of Pheon Therapeutics. He is recognized as a veteran biotech leader with experience in fundraising and company building.
Full founder directory · Investor directory · Company funding database · Fundraising library